A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans.

Journal of drugs in dermatology : JDD

Volumn 4, Issue 1, 2005, Pages 29-34

  Gallup, Elizabeth ^a   Plott, Todd ^a  

^a Medical Strategies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CICLOPIROX; PYRIDONE DERIVATIVE;

ARTICLE; CLINICAL TRIAL; DERMATITIS; DIAPER DERMATITIS; FEMALE; HUMAN; INFANT; MALE; MICROBIOLOGY; MUCOCUTANEOUS CANDIDIASIS; MULTICENTER STUDY; PATHOLOGY; PRESCHOOL CHILD; SUSPENSION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANTIFUNGAL AGENTS; CANDIDIASIS, CUTANEOUS; CHILD, PRESCHOOL; DERMATITIS; DIAPER RASH; FEMALE; HUMANS; INFANT; MALE; PYRIDONES; SUSPENSIONS; TREATMENT OUTCOME;

EID: 17544378659     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)